HSPA1A and breast cancer: For HSP70-2 polymorphism, we found that heterogeneity significantly reduced or removed among Africans, mixed populations, and hepatocellular and breast cancers but not among Asians, Europeans, other cancers, population-based, and hospital-based populations.